MTHFR and Recurrent Miscarriage: The Vascular Connection Nobody Explained to You

Recurrent miscarriage — defined as three or more consecutive pregnancy losses — affects approximately 1-2% of couples trying to conceive. For most of them, the standard investigations come back inconclusive. Chromosomal abnormalities are ruled out. Anatomical causes are excluded. And the couple is sent away with the devastating verdict: 'unexplained recurrent miscarriage.'

But there is a biological explanation that is consistently underinvestigated — and that affects a significant proportion of women with recurrent pregnancy loss. That explanation is impaired methylation, elevated homocysteine, and the MTHFR gene variant.

The Vascular Mechanism

The placenta is a vascular organ — its entire function depends on the development and maintenance of a dense network of blood vessels connecting maternal and fetal circulation. This vascular development requires adequate folate, active B vitamins, and normal homocysteine levels at every stage of early pregnancy.

Elevated homocysteine directly damages the vascular endothelium — the cell layer lining blood vessels. In the placenta, this vascular damage produces placental insufficiency, impaired trophoblast invasion (the process by which the embryo implants and establishes blood supply), and increased risk of thrombosis in placental blood vessels. The result is a placenta that cannot sustain the pregnancy — producing loss that is classified as 'unexplained' because no one measured homocysteine.

The Research Evidence

Multiple studies have found elevated rates of MTHFR variants in women with recurrent miscarriage compared to controls. A 2000 meta-analysis found that MTHFR C677T was associated with a significant increase in recurrent pregnancy loss. Studies examining homocysteine levels in women with recurrent miscarriage consistently find elevated levels compared to women with successful pregnancies. A 2012 study found that treating hyperhomocysteinaemia in women with recurrent miscarriage with B vitamins significantly reduced subsequent miscarriage rates.

Homocysteine and Implantation Failure

Beyond miscarriage, elevated homocysteine is increasingly recognised as a factor in implantation failure in IVF and other assisted reproduction cycles. Homocysteine impairs the endometrial receptivity required for successful implantation, and elevated levels at the time of embryo transfer are associated with significantly reduced implantation rates in multiple IVF cohort studies.

What to Do

If you have experienced recurrent miscarriage, ask your GP for a homocysteine test and MTHFR genetic testing. These are straightforward investigations that are often not included in standard recurrent miscarriage workups. If homocysteine is elevated or MTHFR variants are identified, supplementation with methylfolate, methylcobalamin B12, and P5P B6 to lower homocysteine before the next conception attempt is a biologically rational and evidence-supported step.

NeuroThrive™ products are food supplements and are not intended to diagnose, treat, or cure any medical condition. Recurrent miscarriage requires medical investigation and should always be managed with professional guidance. This article is for educational purposes only. Always consult your GP or specialist.